Skip to content

Ringer's Lactate Versus Normal Saline in Caesarean Section

Effect of Ringer's Lactate on Maternal and Neonatal pH in Caesarean Section at Mulago Hospital, a Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01585740
Enrollment
500
Registered
2012-04-26
Start date
2011-09-30
Completion date
2012-05-31
Last updated
2012-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Normal Anion Gap Metabolic Acidosis

Keywords

Hyperchloraemic metabolic acidosis, Neonatal acidosis, Neonatal hyperchloraemia, Base excess, Metabolic acidosis, Caesarean section, Normal saline, Ringer's Lactate, Postoperative morbidity

Brief summary

The objective of this study is to compare the effect on mean maternal and neonatal pH, and 24-hour postoperative morbidity, following intraoperative infusion of Ringer's Lactated versus normal saline in caesarean section at Mulago Hospital. The null hypothesis is that intraoperative infusion of Ringer's Lactate in caesarean section at Mulago Hospital will not result in 30% less mean maternal and neonatal pH change than intraoperative infusion of normal saline.

Detailed description

Fluid therapy in caesarean section surgery in Mulago Hospital is done mostly with 0.9% normal saline (NS). Several studies have highlighted the complications associated with large infusion of normal saline. Few studies have compared the effects of an alternative crystalloid, Ringer's Lactate (RL), on perinatal pH and postoperative morbidity in caesarean section surgery. This trial will be performed in Mulago Hospital Labour Ward theatre on parturients who consent and are scheduled for either elective or emergency caesarean section under spinal anaesthesia from September 2011 to May 2012. Study fluid will be administered intraoperatively only. Preoperative and postoperative venous blood samples will be drawn for venous blood gases, serum urea and creatinine. Placental umbilical arterial cord blood will also be drawn for neonatal arterial blood gases. Mothers will be followed up for 24 hours for incidence of postoperative morbidity.

Interventions

DRUG0.9% Normal Saline

Crystalloid fluid

DRUGRinger's Lactate

Crystalloid fluid

Sponsors

Makerere University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* All parturients who consent for the study. * Up to American Society of Anesthesiology (ASA) class ІІ/E.

Exclusion criteria

* Failed spinal anaesthesia that has to be converted to general anaesthesia.

Design outcomes

Primary

MeasureTime frameDescription
Change in Maternal pH from preoperative baselineIntraoperativelyThe aim is to study the effect of the study fluid on maternal pH. pH will be measured preoperatively and immediately postoperatively before the patient leaves the recovery room.

Secondary

MeasureTime frameDescription
Neonatal pHWithin 30 seconds of umbilical cord ligatureA sample of umbilical arterial cord blood will be drawn after ligating the cord to measure neonatal pH
Change in maternal base excess from preoperative baselineIntraoperativelyThe aim is to study the effect of the study fluid on maternal base excess. Base excess will be measured preoperatively and immediately postoperatively before the patient leaves the recovery room.
Number of mothers with postoperative morbidity events24 hours postoperativelyUsing a Post-Operative Morbidity Survey (POMS) mothers will be followed up postoperatively for 24 hours assessing incidence of morbidity in the following systems: Pulmonary, Renal, Gastrointestinal, Cardiovascular, Neurological, and Hematological.

Countries

Uganda

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026